Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Avid Radiopharmaceuticals
Age
55–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Scan Reader Criteria (5 total readers):
Board-certified in radiology or nuclear medicine
Professional experience interpreting PET scans
Scan Criteria (205 total scans):
Former enrollment in AZES Study
Flortaucipir scan at baseline
clinical dementia rating - sum of boxes (CDR-SB) assessment at 18 months
Scan Study Population (AZES Study):
55 to 85 years
MCI due to AD or probable AD by National Institute on Aging-Alzheimer's Association criteria (Albert 2011
mini-mental status exam (MMSE) of 20 to 30 inclusive
CDR global score of 0.5 (MCI), or 0.5 or 1 (AD) with a memory box score ≥ 0.5, and a score of ≤85 on the Delayed Memory Index of the Repeatable Battery for the Assessment of Neuropsychological Status.
Amyloid positive status confirmed by florbetapir PET or lumbar puncture
